Mannitol Demo

Mannitol, the active ingredient in Mannitol Demo, is an osmotic diuretic presented as a intravenous solution for intravenous use. It treats increased intracranial pressure, acute renal failure, oliguria and glaucoma in appropriate clinical settings.

GNH USA supplies Mannitol Demo as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Mannitol is an osmotic agent used in conditions where reduction of intracranial or intra‑ocular pressure and promotion of diuresis are required.

- Increased intracranial pressure: reduces cerebral edema and lowers intracranial pressure. - Acute renal failure: improves renal perfusion and increases urine output. - Oliguria: stimulates diuresis to raise urine volume. - Glaucoma: lowers intra‑ocular pressure by osmotic fluid shift.

Mannitol may cause a range of adverse reactions, from mild to severe, depending on patient factors and dosing.

Common Side Effects: - Headache: mild to moderate discomfort often related to rapid fluid shifts. - Nausea: transient feeling of unease or urge to vomit. - Electrolyte imbalance: changes in sodium or potassium levels. - Thirst: increased sensation of dryness in the mouth.

Serious or Rare Side Effects: - Pulmonary edema: fluid accumulation in the lungs requiring urgent care. - Severe dehydration: excessive fluid loss leading to hypotension. - Acute renal failure: sudden decline in kidney function. - Anaphylactic reaction: severe allergic response with airway compromise.

When using Mannitol, clinicians should observe several safety measures to minimize risk.

- Monitor serum electrolytes: check sodium and potassium levels regularly. - Assess renal function: avoid or adjust use in patients with severe renal impairment. - Evaluate fluid status: ensure adequate hydration before infusion. - Use cautiously in heart failure: risk of volume overload and pulmonary congestion. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with other medications, affecting efficacy or safety.

Major Interactions (Avoid): - Loop diuretics: may cause excessive diuresis and electrolyte loss. - Insulin: can potentiate hypoglycemia due to osmotic shifts. - ACE inhibitors: increase risk of renal dysfunction.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive blood pressure lowering effect. - NSAIDs: may reduce diuretic response. - Lithium: altered renal clearance may raise lithium toxicity risk.